News
Accèdez sans limite aux 15 000 actualités du site et recevez gratuitement chaque semaine, la Newsletter Santé log avec les ...
Accèdez sans limite aux 15 000 actualités du site et recevez gratuitement chaque semaine, la Newsletter Santé log avec les ...
NurExone’s acceptance into the prestigious HTH Accelerator Program will support the Company’s expansion into the U.S. market following the establishment of Exo-top Inc. (“ Exo-TOP ”), the Company’s ...
Sanofi and Regeneron are committed to helping patients in the US who are prescribed Dupixent gain access to the medicine and receive the support they may need with the DUPIXENT MyWay® program. For ...
Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP) Approval based on pivotal results showing improvements in sustained disease ...
GLP-1 medications have emerged as a physician-supervised option for individuals managing obesity or weight-related conditions ...
Illuccix® (kit for the preparation of gallium-68 ( 68 Ga) gozetotide injection), Telix’s first generation PSMA-PET imaging agent, has been approved in multiple countries globally. TLX591, TLX252 and ...
Neuronetics, Inc. believes that mental health is as important as physical health. As a global leader in neuroscience, Neuronetics is delivering more treatment options to patients and physicians by ...
Ensign has been a dividend-paying company since 2002.
In connection with this process, the Board of Directors has approved a targeted retention and incentive framework for certain key executives. These measures, that replace the existing bonus program, ...
In addition, MSL has secured coverage for several other major carriers, including UHC, Aetna, Cigna, and Humana, through contracts with Medical Cost Containment Professional (MCCP), Unity Preferred ...
Dr. Ahmed’s approach is rooted in collaboration with community members, local organizations, and city leaders. Rather than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results